Hyun Cheol Chung

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 18

Top Topics

Advanced Non Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Circulating Tumor

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Yonsei medical journal

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Choong-Kun Lee, Sejung Park, Chung-Mo Nam, Hyun Cheol Chung, Sun Young Rha
Reply to B. Freidlin et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Hyun Cheol Chung, Esma Saada-Bouzid, Federico Longo, Eduardo Yanez, Seock-Ah Im, Eduardo Castanon, Danielle N Desautels, Donna M Graham, Javier Garcia-Corbacho, Juanita Lopez, Corina Dutcus, Chinyere E Okpara, Razi Ghori, Fan Jin, Roman Groisberg, Iphigenie Korakis
Lenvatinib plus pembrolizumab for patients with previously treated, advanced, triple-negative breast cancer: Results from the triple-negative breast cancer cohort of the phase 2 LEAP-005 Study. Cancer 130 (19) (2024)
Choong-Kun Lee, Sejung Park, Chung-Mo Nam, Hyun Cheol Chung, Sun Young Rha
Reply to B. Freidlin et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Hyun Cheol Chung, Esma Saada-Bouzid, Federico Longo, Eduardo Yanez, Seock-Ah Im, Eduardo Castanon, Danielle N Desautels, Donna M Graham, Javier Garcia-Corbacho, Juanita Lopez, Corina Dutcus, Chinyere E Okpara, Razi Ghori, Fan Jin, Roman Groisberg, Iphigenie Korakis
Lenvatinib plus pembrolizumab for patients with previously treated, advanced, triple-negative breast cancer: Results from the triple-negative breast cancer cohort of the phase 2 LEAP-005 Study. Cancer (2024)
Choong-Kun Lee, Sejung Park, Chung-Mo Nam, Hyun Cheol Chung, Sun Young Rha
Reply to B. Freidlin et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Seung Hyun Jung, Choong-Kun Lee, Woo Sun Kwon, Sujin Yun, Minkyu Jung, Hyo Song Kim, Hyun Cheol Chung, Yeun-Jung Chung, Sun Young Rha
Monitoring the Outcomes of Systemic Chemotherapy Including Immune Checkpoint Inhibitor for HER2-Positive Metastatic Gastric Cancer by Liquid Biopsy. Yonsei medical journal 64 (9) (2023)
Do Youn Oh, Alain Algazi, Jaume Capdevila, Federico Longo, Wilson Miller, Jerry Tan Chun Bing, Carlos Eduardo Bonilla, Hyun Cheol Chung, Tormod K Guren, Chia-Chi Lin, Daniel Motola-Kuba, Manisha Shah, Julien Hadoux, Lili Yao, Fan Jin, Kevin Norwood, Loïc Lebellec
Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE-158 study. Cancer (2023)
Do Youn Oh, Alain Algazi, Jaume Capdevila, Federico Longo, Wilson Miller, Jerry Tan Chun Bing, Carlos Eduardo Bonilla, Hyun Cheol Chung, Tormod K Guren, Chia-Chi Lin, Daniel Motola-Kuba, Manisha Shah, Julien Hadoux, Lili Yao, Fan Jin, Kevin Norwood, Loïc Lebellec
Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE-158 study. Cancer 129 (8) (2023)
Choong-Kun Lee, Hyo Song Kim, Minkyu Jung, Hyunki Kim, Woo Kyun Bae, Dong-Hoe Koo, Hei Cheul Jeung, Sook Ryun Park, In Gyu Hwang, Dae Young Zang, Hyun Woo Lee, Sejung Park, Chung-Mo Nam, Hyun Cheol Chung, Sun Young Rha
Open-Label, Multicenter, Randomized, Biomarker-Integrated Umbrella Trial for Second-Line Treatment of Advanced Gastric Cancer: K-Umbrella Gastric Cancer Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Chang Gon Kim, Minkyu Jung, Hyo Song Kim, Choong-Kun Lee, Hei-Cheul Jeung, Dong-Hoe Koo, Woo Kyun Bae, Dae Young Zang, Bum Jun Kim, Hyunki Kim, Un-Jung Yun, Jingmin Che, Sejung Park, Tae Soo Kim, Woo Sun Kwon, Juin Park, Sang Woo Cho, Chung-Mo Nam, Hyun Cheol Chung, Sun Young Rha
Trastuzumab Combined With Ramucirumab and Paclitaxel in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Advanced Gastric or Gastroesophageal Junction Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Do Youn Oh, Alain Algazi, Jaume Capdevila, Federico Longo, Wilson Miller, Jerry Tan Chun Bing, Carlos Eduardo Bonilla, Hyun Cheol Chung, Tormod K Guren, Chia-Chi Lin, Daniel Motola-Kuba, Manisha Shah, Julien Hadoux, Lili Yao, Fan Jin, Kevin Norwood, Loïc Lebellec
Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE-158 study. Cancer 129 (8) (2023)
Kensei Yamaguchi, Yung-Jue Bang, Satoru Iwasa, Naotoshi Sugimoto, Min-Hee Ryu, Daisuke Sakai, Hyun Cheol Chung, Hiasto Kawakami, Hiroshi Yabusaki, Jeeyun Lee, Tatsu Shimoyama, Keun-Wook Lee, Kaku Saito, Yoshinori Kawaguchi, Takahiro Kamio, Akihito Kojima, Masahiro Sugihara, Kohei Shitara
Trastuzumab Deruxtecan in Anti-Human Epidermal Growth Factor Receptor 2 Treatment-Naive Patients With Human Epidermal Growth Factor Receptor 2-Low Gastric or Gastroesophageal Junction Adenocarcinoma: Exploratory Cohort Results in a Phase II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Kwang Seob Lee, Jieun Seo, Choong-Kun Lee, Saeam Shin, Zisun Choi, Seungki Min, Jun Hyuek Yang, Woo Sun Kwon, Woobin Yun, Mi Ri Park, Jong Rak Choi, Hyun Cheol Chung, Seung Tae Lee, Sun Young Rha
Analytical and Clinical Validation of Cell-Free Circulating Tumor DNA Assay for the Estimation of Tumor Mutational Burden. Clinical chemistry 68 (12) (2022)
Keun-Wook Lee, Eric Van Cutsem, Yung-Jue Bang, Charles S Fuchs, Iveta Kudaba, Marcelo Garrido, Hyun Cheol Chung, Jeeyun Lee, Hugo R Castro, Joseph Chao, Zev A Wainberg, Z Alexander Cao, Deepti Aurora-Garg, Julie Kobie, Razvan Cristescu, Pooja Bhagia, Sukrut Shah, Josep Tabernero, Kohei Shitara, Lucjan Wyrwicz
Association of Tumor Mutational Burden with Efficacy of Pembrolizumab±Chemotherapy as First-Line Therapy for Gastric Cancer in the Phase III KEYNOTE-062 Study. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (16) (2022)
Torben Steiniche, Sun Young Rha, Hyun Cheol Chung, Jeanette Baehr Georgsen, Morten Ladekarl, Marianne Nordsmark, Marie Louise Jespersen, Hyo Song Kim, Hyunki Kim, Carly Fein, Laura H Tang, Ting Wu, Matthew J Marton, Senaka Peter, David P Kelsen, Geoffrey Ku
Prognostic significance of T-cell-inflamed gene expression profile and PD-L1 expression in patients with esophageal cancer. Cancer medicine 10 (23) (2021)
Hyun Cheol Chung, Yoon-Koo Kang, Zhendong Chen, Yuxian Bai, Wan Zamaniah Wan Ishak, Byoung Yong Shim, Young Lee Park, Dong-Hoe Koo, Jianwei Lu, Jianming Xu, Hong Jae Chon, Li-Yuan Bai, Shan Zeng, Ying Yuan, Yen-Yang Chen, Kangsheng Gu, Wen Yan Zhong, Shu Kuang, Chie-Schin Shih, Shu-Kui Qin
Pembrolizumab versus paclitaxel for previously treated advanced gastric or gastroesophageal junction cancer (KEYNOTE-063): A randomized, open-label, phase 3 trial in Asian patients. Cancer (2021)
Hyun Cheol Chung, Yung-Jue Bang, Charles S Fuchs, Shu-Kui Qin, Taroh Satoh, Kohei Shitara, Josep Tabernero, Eric Van Cutsem, Maria Alsina, Zhu Alexander Cao, Jia Lu, Pooja Bhagia, Chie-Schin Shih, Yelena Y Janjigian
First-line pembrolizumab/placebo plus trastuzumab and chemotherapy in HER2-positive advanced gastric cancer: KEYNOTE-811. Future oncology (London, England) 17 (5) (2020)
Su-Jin Shin, Sejung Park, Min Hwan Kim, Chung Mo Nam, Hyunki Kim, Yoon Young Choi, Min Kyu Jung, Hye Jin Choi, Sun Young Rha, Hyun Cheol Chung
Mesothelin Expression Is a Predictive Factor for Peritoneal Recurrence in Curatively Resected Stage III Gastric Cancer. The oncologist 24 (11) (2019)